Replies to post #188731 on Avid Bioservices Inc (CDMO)

[corporalagarn]

The announcement of the plethora of unannounced collaborations would do the trick. Short of that, it would have to be great interim results, and we will not see those for quite a while.

[Protector]

Yes, but don't expect it tomorrow.

I still envisage first partnership Q1/Q2 2015 and not earlier but there may be some indication in the coming periods (maybe not direct but indirect on a CC or annual).

And I don't think such first partnership would shoot us directly to 10$ either, hence my 'future' reference. But I think that a partnership would give sufficient support to start the climb.

We WILL need 2nd ln NSCLC PIII stat sig data for the big shoot. However, if an early partnership would be on Bavi Oncology (not Cotara, Bavi Viral/Imaging, or IP licensing only) then it will be the raw structure for the stock to grow towards that PIII. In other words the PPS will anticipate and go up and the jump on announcement will be smaller (part of it will already be in the pps). In both scenario's that is where we should easily make 10$.

If however we have the luck that the clinical trial is stopped early by the data monitoring commission and the announcement is by surprise, then we have seen nothing yet.

However, IF, IF, IF but that is investing.